Goodwin advised Myrobalan Therapeutics on the matter. Myrobalan Therapeutics has been granted $400,000 from the ALS Association to support the advancement of its colony-stimulating factor-1 receptor...
Myrobalan Therapeutics’ $400,000 Grant from ALS Association
Myrobalan Therapeutics’ $24 Million Series A Funding Round
Goodwin represented Myrobalan Therapeutics on the matter. Myrobalan Therapeutics announced its $24 million Series A financing. The round was led by Co-win Ventures, with participation from...